Cathy Harrison/LinkedIn
Jun 24, 2025, 08:09
Cathy Harrison Shares Study on Deprescribing Antithrombotic Therapy in Advanced Cancer Care
Cathy Harrison, WFH nurses committee Chair, shared a post on X:
“Incredibly interesting, mixed methods study on antithrombotic therapy (ATT) during advanced cancer care. Experienced clinicians we’re more likely to deprescribe ATT and patient choice was a key decision maker in that action.”
Don’t miss updates from ISTH 2025 with Hemostasis Today.
-
Aug 8, 2026, 05:23Mohsin Naseer։ From Beginner to Published Researcher
-
Aug 8, 2026, 04:50Marc Carrier: Celebrating 20 Years with ASH CRTI
-
Aug 8, 2026, 04:37Megan Adediran: Building Confidence for a Life Beyond Haemophilia
-
Aug 8, 2026, 04:32Megan Kavanaugh Roussos: Airborne Medical Expands Portfolio with WoundClot Advanced Hemostatic Technology
-
Aug 8, 2026, 04:25Maymoon Madkhali։ First Report of a Rare D– – Blood Phenotype in Saudi Arabia
-
Aug 8, 2026, 04:13Alexandra Bernal: Uncovering the Anticoagulant Role of Factor V in Hemophilia A
-
Aug 8, 2026, 04:03Wellington Fernandes: Honored to Join the Faculty of Medicine of USP as Professor of Hematology
-
Aug 8, 2026, 04:01Noa Ezra: How Senescent Cardiac Cells Drive a Pro-Thrombotic State
-
Aug 8, 2026, 03:56Omid Khalafi: PCT – The Platelet Parameter Almost Everyone Ignores